About GSPH

Donald S. Burke, MD

GSPH for You

Graduate School of Public Health is a top-ranked, world-renowned institution with contributions that have influenced public health practices and medical care in the Pittsburgh region as well as all across the world.

 Donald S. Burke, MD

Dean, Graduate School of Public Health
UPMC - Jonas Salk Chair in Global Health
Associate Vice Chancellor for Global Health
Director, Center for Vaccine Research

130 DeSoto Street
A624 Crabtree Hall
Pittsburgh, PA 15261
Telephone: 412-624-3001
Fax: 412-624-3309
E-mail: donburke@pitt.edu

Education and TrainingHonors and AwardsEditorials
Medical LicensureProfessional ActivitiesPeer Reviewed Journal Articles
Positions HeldOther Professional Interests 

Education and Training

• Bachelor of Arts Degree, Western Reserve University, Cleveland, Ohio, 1967 (chemistry major; honors in biology; magna cum laude; Phi Beta Kappa)
• Doctorate in Medicine, Harvard Medical School, Boston, Massachusetts, 1971
• Clinical Fellow in Medicine (Intern & Junior Resident Physician), Harvard University and the Boston City Hospital, Boston, Massachusetts, 1971-73
• Clinical Fellow in Medicine (Senior Resident Physician), Harvard University and the Massachusetts General Hospital, Boston, Massachusetts, 1975-76
• Research Fellow in Infectious Diseases, Walter Reed Army Medical Center, Washington, DC, 1976-78

 

Medical Licensure

• Certified, Diplomat in the Specialty of Internal Medicine, American Board of Internal Medicine, 1977
• Certified, Diplomat in the Sub-Specialty of Infectious Diseases, American Board of Internal Medicine, 1978
• Medical License, State of Maryland, through 30 September 2009, with identification as a Specialist in Internal Medicine and in Infectious Diseases

Back to top

 

Positions Held

2006-Present

• Dean, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
• Associate Vice Chancellor for Global Health, University of Pittsburgh, Pittsburgh, PA
• Director, Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA

2002-2006

Associate Department Chairman and Program Director, Disease Prevention and Control Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health. Led 42 full time Disease Prevention and Control faculty. Elected by vote of the faculty in 2002, re-elected in 2005.

1997-2006

Professor of International Health and Professor of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and Professor of Medicine, Johns Hopkins School of Medicine, and Director, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health. Principal Investigator, Johns Hopkins Cameroon Program, 1998-2003; Principal Investigator, Johns Hopkins HIV Vaccine Trials Unit (National Institutes of Health / NIAID, 1999-2006); Co-Principal Investigator, Mid-Atlantic Regional Center of Excellence for Biodefense (National Institutes of Health / NIAID, 2003-2006); Principal Investigator, “MIDAS” Modeling of Infectious Disease Agents Study (National Institutes of Health / NIGMS, 2004-present).

1996-1997

Associate Director for Emerging Threats and Biotechnology, Walter Reed Army Institute of Research (WRAIR), Washington, DC. Responsible for design and implementation of research programs on infectious diseases of military importance and new technologies in biomedicine. Coordinated global research activities on surveillance, diagnosis, prevention, and treatment of emerging infectious diseases. Retired from the US Army Medical Corps in 1997 as a Colonel after 23 years of active duty service.

1990-1996

Director, US Military HIV/AIDS Research Program, Rockville, MD. A nation-wide Army, Navy, and Air Force cooperative effort aimed at controlling HIV/AIDS in military populations. Directly or indirectly supervised and coordinated activities of 50 doctoral level and 150 technical and administrative personnel. Served as Area Manager for HIV/AIDS Research, US Army Medical Research and Material Command, responsible for distribution and management of retrovirus research funds, which averaged $30 million per year. Emphasis on basic and applied research on HIV/AIDS vaccines.

1988-1990

Director, Division of Retrovirology, WRAIR, Washington, DC. Founder and Director, US Military HIV/AIDS Laboratory Complex, Rockville, Maryland. Responsible for design and conduct of US Military HIV/AIDS medical research studies, and for the management and direction of a 28,000 sq ft. laboratory complex of co-located Government, Jackson Foundation, and contractor facilities. Continued responsibilities for ongoing military HIV screening and medical staging programs.

1984-1988

Chief, Department of Virus Diseases, WRAIR, Washington, DC. Responsible for the intramural research program on virus diseases of military importance, especially HIV/AIDS, flaviviruses, and hepatitis viruses. Responsible for the design and conduct of US military HIV screening and medical staging programs.

1978-1984

Chief, Virology Department, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand. Responsible for the design and conduct of research on tropical viruses of military importance, especially dengue and Japanese encephalitis viruses. Emphasis on studies related to vaccine development and testing. Also served as Deputy Director, AFRIMS, 1983-84.

1976-1978

Clinical Desk Officer, Department of Virus Diseases, WRAIR. Responsible for diagnostic virology at Walter Reed Army Medical Center . Simultaneously fulfilled clinical responsibilities as an Infectious Disease Fellow.

1973-1975

Clinical Ward Officer and Chief, Medical Division, US Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland. Responsible for occupational health of research workers in the high containment laboratories at USAMRIID. Conducted studies on vaccines against infectious disease agents of military significance.

Back to top

 

Honors and Awards

Medical and Public Health Societies

• Nathaniel A. Young Memorial Award of the American Committee on Arthropod-borne Viruses, American Society of Tropical Medicine and Hygiene, for outstanding contributions to arbovirology by a scientist under the age of 45 years, 1989
• Kimble Methodology Award of the Conference of Public Health Laboratorians, for outstanding contributions to Public Health by development and implementation of HIV diagnostics, 1989
• Bailey K. Ashford Medal of the American Society of Tropical Medicine and Hygiene, for outstanding achievements in tropical medicine by a society member under the age of 45 years, 1990
• Sustaining Membership Award, Association of Military Surgeons of the US, for outstanding contributions to medical research, 1992
• Elected President, American Society of Tropical Medicine & Hygiene, 1995-1996
• Golden Apple Award (best teacher), Johns Hopkins School of Hygiene and Public Health, 1998-1999
• Elected Fellow, American Academy of Microbiology, 2000
• Elected Member, Delta Omega Public Health Honorary Society, 2000
• Elected Fellow, American Association for the Advancement of Science (Medical Science), 2003
• Elected Fellow, American Epidemiological Society, 2006
• UPMC-Jonas Salk Chair in Global Health, University of Pittsburgh, 2006-present
• Ambassador, Paul G. Rogers Society for Global Health Research, 2007
• Lifetime National Associate of the National Research Council for "Extraordinary Service to the NRC and the Academies", 2008

Visiting Professorships and Honorary Lectures

• Dartmouth Medical School and Dartmouth College, Visiting Professor, 15-16 April 1993
• Tulane University School of Public Health and Tropical Medicine, Visiting Professor, 1-3 March 1994
• Harvard Medical School, Department of Microbiology and Molecular Genetics, Visiting Lecturer, 28 February 1995
• University of Pittsburgh School of Medicine, Department of Molecular Genetics and Biochemistry, Visiting Professor, 1-2 May 1995
• Presidential Address, American Society of Tropical Medicine and Hygiene, Baltimore, Maryland, 3 December 1996
• Chapman Binford Memorial Lecturer, American Society of Microbiology, Atlanta, Georgia, 9 November 1997
• Invited Lecturer, 50 th Anniversary Celebration of the University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, 19 February 1999
• Thomas Francis, Jr. Annual Memorial Lecturer, University of Michigan School of Public Health, Ann Arbor, Michigan, 28 March 2001
• Distinguished Scientist Seminar, Marine Biological Laboratory, Woods Hole, Massachusetts, 8 November 2002
• Centennial Anniversary Lecturer, American Society of Tropical Medicine and Hygiene, Philadelphia, Pennsylvania, 3 December 2003
• Invited Lecturer, Annual Meeting of the National Academy of Sciences, Washington DC, 20 April 2004
• Keynote Address, Annual Symposium, New York Academy of Medicine and the Royal Society of Medicine, New York, New York, 13 June 2005
• John C. Cutler Memorial Lecturer, University of Pittsburgh Graduate School of Public Health, 26 September 2006
• Keynote Address, Annual Meeting of the US Department of Defense Global Emerging Infection Surveillance and Response System, Louisville, Kentucky, 6 August 2007
• Keynote Address, Institute of Medicine Forum on Microbial Threats, Washington, DC, 4 December 2007
• Invited Lecturer, "Science with the Stars", Walter Reed Army Institute of Research Seminar Series, Silver Springs, Maryland, 16 June 2008
• Keynote Address, Tulane University President's Symposium, New Orleans, Louisiana, 5 December 2008
• O. Ray Kling Distinguished Lecturer, Public Health Grand Rounds, University of Oklahoma, Oklahoma City, Oklahoma, 8 April 2009 

Military Honors

• National Defense Service Medal, 1973
• Army Service Ribbon, 1973
• Army Commendation Medal, 1975
• Meritorious Service Medal, 1978
• Humanitarian Service Medal, 1981
• Armed Forces Reserve Medal, 1984
• Overseas Ribbon, 1984
• Meritorious Service Medal, First Oak Leaf Cluster, 1985
• Meritorious Service Medal, Second Oak Leaf Cluster, 1986
• Order of Military Medical Merit, 1989
• Department of the Army "A" Proficiency Designator, Infectious Diseases, 1990
• National Defense Service Medal, First Oak Leaf Cluster, 1991
• Meritorious Service Medal, Third Oak Leaf Cluster, 1991
• Legion of Merit, 1997

Back to top

 

Professional Activities

Society Membership and Leadership

• Chairman, Pediatric Dengue Vaccine Initiative
• Elected Fellow, American Association for the Advancement of Science
• Elected Fellow, American Academy of Microbiology
• President (1995-96), American Society of Tropical Medicine and Hygiene
• Elected Fellow, American Epidemiological Society
• Fellow, Royal Society of Tropical Medicine and Hygiene (U.K.)
• Fellow, American College of Physicians
• Fellow, Infectious Disease Society of America
• Member, American Public Health Association
• Member, Physicians for Human Rights
• Member, American Society for Virology
• Member, American Association for the History of Medicine
• Member, International AIDS Society
• Member, Institute of Medicine of the National Academies

Consultations, Panels, and Boards

1. World Health Organization/SE Asia Regional Office, Temporary Advisor, on Research in Viral Hemorrhagic Fevers, 1980; on Dengue Hemorrhagic Fever, 1983; on Viral Hepatitis, 1984
2. Steering Committee on Dengue Vaccines, World Health Organization, Member, 1985-1988
3. Americans for a Sound AIDS Policy (ASAP) Advisory Council, Member, 1987-1992
4. AIDS Vaccine Research and Development Subgroup, US Public Health Service, DoD representative, 1987-1992
5. HIV Early Care Advisory Group, American Medical Association, Member, 1989-1990
6. Diagnostic and Therapeutic Technology Assessment Panel, American Medical Association, Member, 1989-1991
7. Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine, Member, 1989-1994
8. International Forum on AIDS Research, Institute of Medicine, Member, 1990-1992
9. Steering Committee on AIDS/HIV Vaccine Development, World Health Organization, Member, 1991-1994
10. HIV/AIDS Working Group, Center for Strategic and International Studies, Member, 1992-1994
11. Mahidol University, Consultant, Post-graduate Training in Virology in Response to the HIV/AIDS Epidemic, Bangkok, Thailand, 1993
12. Civil-Military Alliance Against HIV/AIDS, Co-Founder, 1993
13. Working Group on HIV Vaccine Development and International Field Trials of the Federal Coordinating Committee on Science, Engineering and Technology Committee on Life Sciences and Health, Co-Chairman, 1992-1994
14. Pharmaceutical Organization, Royal Thai Government, Consultant, on Local Production of HIV Vaccines, 1994
15. AIDS Vaccine Trials Data and Safety Monitoring Board, Member, National Institutes of Health, 1988-1996
16. UNAIDS, Temporary Advisor on HIV Molecular Epidemiology, 1996 and 2000
17. Vice-President’s Working Group on HIV Vaccines and Therapeutics, White House, Member, 1996
18. American Association of Blood Banks, Consultant, Think Tank on Emerging Viruses, 1996
19. Ministry of Agriculture, Government of New Zealand, Consultant, on Rabbit Hemorrhagic Disease Virus as a Bio-control Agent, 1997
20. National Institutes of Health Study Section on Tropical Medicine and Parasitology, Member, 1997-2000
21. Food and Drug Administration, Transmissible Spongiform Encephalopathies Advisory Committee, Member, 1998-2002
22. National Research Council, Panel on Climate, Ecology, Infectious Diseases, and Health, Chairman, 1999-2001
23. Institute of Medicine, Department of Defense Global Emerging Infectious Surveillance Committee, Member, 2000-2001
24. International Research Institute for Climate Prediction of Columbia University, Scientific Advisory Committee, Member, 2000-2003
25. Institute of Medicine, Committee on Emerging Microbial Threats to Health in the 21st Century, Member, 2001-2003
26. Smallpox Computational Modeling Working Group, Office of Public Health Emergency Preparedness, US Department of Health and Human Services, Member, 2002-2004
27. SARS Task Force, Defense Science Board, Department of Defense, Member, 2003-2004
28. National Biodefense Analysis and Countermeasure Center, Department of Homeland Security, Working Group on Threat Prioritization, Chair, Virology Group, 2003-2004
29. Federation of American Scientists, Biosecurity Education for Biology Graduate Students Project, Temporary Advisor, 2004
30. International AIDS Vaccine Initiative, Co-founder, 1994-96; Senior Scientific Advisor, 1997-2002; Policy Advisory Board Member, 2003-present
31. Institute of Medicine, Department of Defense/Veterans Affairs Medical Follow-up Agency, Member of the Board, 2002-2006
32. Physicians for Human Rights/Health Action AIDS, Executive Committee, 2003-present
33. Data Safety and Monitoring Board, HIV Phase III Clinical Trial (Rayong Thailand), Member, 2004-present
34. Consortium for Conservation Medicine, Executive Committee, 2004-present
35. Bill & Melinda Gates Foundation, Technical Review Panel, HIV/AIDS Vaccines, Member, 2005
36. Special Review Panel of the Joint National Institutes of Health / National Science Foundation Ecology of Infectious Disease Program, Panel Chairman, 2005
37. Jewish Healthcare Foundation, Board Member, 2006-present
38. Community Health Committee of the UPMC Board of Directors, 2006-present
39. National Biodefense Analysis & Countermeasures Center, Science & Technology Advisory Committee, 2006-present
40. NSF IGERT Sociotechnical Systems Advisory Board, 2006
41. Welcome Trust/Bill & Melinda Gates Foundation Ad Hoc Advisory Meeting on Innovation in Research, Delegate, London, 2007
42. Pediatric Dengue Vaccine Initiative, Board of Counselors, 2007-present
43. UPMC Community Health Committee Board of Directors, 2007-present
44. UPMC International Medical and Scientific Advisory Board 2007-present
45. Pittsburgh Regional Health Initiatives Board of Directors, 2007-present
46. Institute of Medicine, Health Sciences Policy Board Member, 2008-present
47. Jewish Health Care Pittsburgh Regional Health Initiative (PRHI) Oversight Committee Member, 2008-present
48. Institute of Medicine, Board on Global Health to Research Needs for Retention of Variola Virus, Member, 2008-present
49. Middle Atlantic Regional Center of Excellence (MARCE) Biosafety and Biocontainment Policies Committee Member, 2008-present
50. NIH Director's Blue Ribbon Panel for the Risk Assessment of the National Emerging Infectious Diseases Laboratories, Member, 2008-present
51. University of Pittsburgh Confucius Institute Advisory Board Member, 2008-present
52. MRC Centre for Outbreak Analysis and Modeling Scientific Advisory Board Member, 2008-present
53. Dengue Vaccine Advocacy Initiative (Sanofi-Pasteur) Steering Committee Member, 2008-present
54. Pennsylvania Tobacco Use Prevention and Cessation Advisory Board Member, 2008-present
55. UPMC/21CB Vaccine Production Steering Committee Member, 2009-present
56. Institute of Medicine Report on Personal Protective Equipment against H1N1 Review Coordinator, 2009-present
57. Pennsylvania's Public Health Law Advisory Committee, 2009-present 

Public Testimonies

1. “Quality Control of HIV Screening,” Subcommittee on Regulation and Business Opportunities, House Small Business Committee, Quality Control of HIV Screening,” Subcommittee on Regulation and Business Opportunities, House Small Business Committee, US Congress, 19 October 1987
2. “Obstacles to Routine Early Diagnosis of HIV,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 4 April 1989
3. “Progress on the Army’s HIV Research Program,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 16 April 1991
4. “Opportunities in AIDS Research,” Subcommittee on Health and the Environment, House Energy and Commerce Committee, US Congress, 24 April 1992
5. “HIV Research in the US Military,” Subcommittee on Defense Technology, Acquisition, and Industrial Base, Senate Armed Services Committee, US Congress, 24 June 1993
6. “Tropical Infectious Disease Research Funding,” Subcommittee on Foreign Operations, Export Financing, and Related Programs, House Committee on Appropriations, US Congress, 31 March 1998
7. “Tropical Infectious Disease Research Funding,” Subcommittee on Defense, Senate Committee on Appropriations, US Congress, 11 May 1998
8. "Infectious Disease Research," Subcommittee on Defense, Senate Committee on Appropriations, US Congress, 29 March 2000
9. “Baltimore City HIV/AIDS Prevention- A Public Health State of Emergency,” Baltimore City Council, 9 October 2002 10. “Tropical Infectious Diseases” Subcommittee on Foreign Operations, Export Financing, and Related Programs, House Committee on Appropriations, US Congress, 2 April 2003

Medical Journals

Editorial Board Member

• AIDS Research and Human Retroviruses, 1987-1989
• Journal of Acquired Immune Deficiency Syndromes, 1988-1998
• American Journal of Tropical Medicine and Hygiene, 1988-1997
• Biosecurity and Bioterrorism, 2002-present
• Epidemics, 2008-present

Editorial Advisory Board Member

• Current Opinions in Infectious Diseases, Section Editor on HIV and AIDS, 1993
• Global Change and Human Health, 2000-2002
• Emerging Infectious Diseases, 1997-present
• Journal of Infectious Diseases, 2008-present

Columnist

• AIDS and Society: International Research and Policy Bulletin, “Vaccine Watch” quarterly column, 1992-1994

Editorial Committee

• Epidemiological Reviews, Vaccines and Public Health, 2005-2006 National Academies Reports

National Academies Reports

National Research Council, Board on Atmospheric Sciences and Climate

• Chairman, Committee on Climate, Ecosystems, Infectious Diseases, and Human Health, 1999-2001
• Issued report entitled “Under the Weather: Climate, Ecosystems, and Infectious Disease,” 2001

National Research Council, Policy and Global Affairs Committee

• Reviewer, Report on “Future Contributions of the Biosciences to Public Health, Agriculture, Basic Research, Counter-terrorism, and Non-Proliferation Activities in Russia,” 2004

National Research Council, Board on Life Sciences

• Review Coordinator, report on “Exploring the role of antiviral drugs in the eradication of polio,” 2006

Institute of Medicine, Medical Follow-up Agency

• Member, Committee to Review the Department of Defense Global Emerging Infections Surveillance and Response System, 2000-2001. Issued report entitled “Perspectives on the Department of Defense Global Emerging Infections Surveillance and Response System: A Program Review,” 2001
• Reviewer, Report on “Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military,” 2002
• Medical Follow-up Agency Board Member, 2002-2006
• Member, Committee on Long-term Health Effects of Participation in Project SHAD, 2003-2006. Report in preparation.

Institute of Medicine, Board on Global Health

• Member, Committee on Emerging Microbial Threats to Health in the 21 st Century, 2001-2003. Issued report entitled “Microbial Threats to Health: Emergence, Detection, and Response,” 2003
• Reviewer, Report on “Human Resources at U.S. Ports of Entry to Protect the Public's Health” (Interim Letter Report), 2004
• Member, Committee on Assessment of Future Scientific Needs for Live Variola Virus, 2008-present

Institute of Medicine, Board on Health Promotion and Disease Prevention

• Reviewer, Report on “ Gulf War and Health: Updated Literature Review of Sarin,” 2004
• Co-Chairman, Committee on Development of Reusable Facemasks for Use during an Influenza Pandemic. Issued report entitled “Facing the Flu: Reusability of Facemasks during an influenza pandemic,” 2006

Institute of Medicine, Board on Health Promotion and Disease Prevention

• Reviewer, Report on “ Gulf War and Health: Updated Literature Review of Sarin,” 2004
• Co-Chairman, Committee on Development of Reusable Facemasks for Use during an Influenza Pandemic. Issued report entitled “Facing the Flu: Reusability of Facemasks during an influenza pandemic,” 2006

Academic and Medical Appointments/US Military

Walter Reed Army Medical Center, Washington, DC

• Attending Physician, Infectious Diseases Service, 1985-1990
• Staff Physician, Department of Medicine, 1985-1997 

U.S. Army Command and General Staff College, Fort Leavenworth, Kansas 

• Faculty, Pre-Command Course, 1990-1992

Uniformed Services University of the Health Sciences, Bethesda, Maryland

• Adjunct Associate Professor, Department of Preventive Medicine/Biometrics, 1985-1992
• Associate Professor, Department of Medicine, 1987-1992
• Professor, Department of Medicine, 1992-1997

Back to top

 

Other Professional Interests

Invited lectures on the history of microbiology and vaccines. Some examples:

• Jesse Lazear of Hopkins: The First Fallen Yellow Fever Hero. Tropical Medicine Dinner Club of Baltimore, Baltimore, Maryland, 8 November 2000
• Malaria Research at Johns Hopkins, 1884 – 1897. Banquet Speaker, Inaugural Meeting of the Johns Hopkins Malaria Institute, Baltimore, Maryland, 27 January 2002
• History of the American Society of Tropical Medicine and Hygiene, 1903-2003. Centennial Celebration Plenary Address, ASTMH, Philadelphia, Pennsylvania, 3 December 2003
• Why Was West Nile Virus Originally Isolated?: Events leading to the virus isolation in Uganda in 1937. Invited Lecture, International Congress of Tropical Medicine and Malaria, Marseille, France, 14 September 2005
• Historical Perspective of Chikungunya Virus Epidemiology and Outbreaks. Invited Lecture, American Society of Tropical Medicine and Hygiene, Washington DC, 15 December 2005
• Serve as Archivist for the American Society of Tropical Medicine and Hygiene and the American Committee on Arthropod-borne Viruses, 1998 – present

Languages

• Thai: Certificate of Literacy (reading and writing), Royal Thai Government, 1983
• French: Fair reading, writing, and speaking abilities

Back to top

 

Editorials

Burke DS. Six Months to Act (Op-Ed on SARS). Wall Street Journal, 25 April 2003 (2003)
Burke DS. Ignoring Deadly Viruses (Op-Ed on avian influenza). Asian Wall Street Journal, 26 January 2004 (2004)
Burke DS. Avian Influenza Is a Threat To Our Collective Security (Op-Ed). Wall Street Journal, 3 November 2005 (2005)

Back to top

 

Peer Reviewed Journal Articles (last 3 years)

1. Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, and Cooley P. Modeling targeted layered containment of an influenza pandemic in the United States, PNAS 10:1073 (2008). PMID: 18332436
2. Vora A, Burke DS, Cummings DA. The impact of a physical geographic barrier on the dynamics of measles. [Electronic publication ahead of print] Epidemiol Infect. Jul 30, 2007: 1-8 (2007). PMID: 17662170
3. Lessler J, Cummings DA, Fishman S, Vora A, Burke DS. Transmissibility of swine flu at Fort Dix, 1976. J Royal Soc Interface 4: 755-62 (2007). PMID: 17412677
4. Torimiro JN, Wolfe ND, Thomas A, Martin MP, Mpoudi-Ngole E, Tamoufe U, Birx DL, Carrington M, Burke DS, Carr JK. Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon. AIDS 21: 527-8 (2007). PMID: 17301575
5. Billings L, Schwartz IB, Shaw LB, McCrary M, Burke DS, Cummings DA. Instabilities in multiserotype disease models with antibody-dependent enhancement. J Theoretical Biology 246: 18-27 (2007). PMID: 17270219
6. Ockenhouse CF, Hu WC, Kester KE, Cummings JF, Stewart A, Heppner DG, Jedlicka AE, Scott AL, Wolfe ND, Vahey M, Burke DS. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun. 2006;74:5561-73 (2006) PMID: 16988231
7. Switzer WM, Hewlett I, Aaron L, Wolfe ND, Burke DS, Heneine W. Serologic testing for human T-lymphotropic virus-3 and -4. Transfusion. 2006;46:1647-8 (2006) Full Text
8. Longini IM Jr, Elizabeth Halloran M, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. Containing a large bioterrorist smallpox attack: a computer simulation approach.. Int J Infect Dis. 2006 Aug 7; PMID:16899385
9. Ferguson NM , Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 442: 448-52 (2006) PMID:16642006
10. Switzer WM, Qari S, Wolfe ND , Burke DS, Folks TM, Heneine W. Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol 80:7427-38 (2006) PMID:16840323
11. Gupta SB, Mast CT, Wolfe ND, Novitsky V, Dubey SA, Kallas EG, Schechter M, Mbewe B, Vardas E, Pitisuttithum P, Burke D, Freed D, Mogg R, Coplan PM, Condra JH, Long RS, Anderson K, Casimiro DR, Shiver JW, Straus WL. Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr 42: 135-9 (2006) PMID: 16760794
12. Oh S, Stegman B, Pendleton CD, Ota MO, Pan CH, Griffin DE, Burke DS, Berzofsky JA. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology 352 :390-9 (2006) PMID: 16781760
13. LeBreton M, Umlauf S, Djoko CF, Daszak P, Burke DS, Kwenkam PY, Wolfe ND. Rift Valley fever in goats, Cameroon. Emerg Infect Dis 12:702-3 (2006) Full text
14. Kuniholm MH, Wolfe ND, Huang CY, Mpoudi-Ngole E, Tamoufe U, Burke DS, Gubler DJ. Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults. Am J Trop Med Hyg 74:1078-83 (2006) PMID: 16760524
15. Cummings DAT, Moss WJ, Long K, Muluh TJ, Kollo B, Nomo E, Wolfe ND, Burke DS. Improved measles surveillance in Cameroon reveals two major dynamic patterns of incidence. Int J Infect Dis 10:148-55 (2006) PMID: 16275043
16. Torimiro JN, Carr JK, Wolfe ND, Karacki P, Martin MP, Gao X, Tamoufe U, Thomas A, Ngole EM, Birx DL, McCutchan FE, Burke DS, Carrington M. HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype. Tissue Antigens. 2006;67:30-7 PMID: 16451198
17. Kalish ML, Wolfe ND, Ndongmo CB, McNicholl J, Robbins KE, Aidoo M, Fonjungo PN, Alemnji G, Zeh C, Djoko CF, Mpoudi-Ngole E, Burke DS, Folks TM. Central African hunters exposed to simian immunodeficiency virus. Emerg Infect Dis 11:1928-30 (2005) Full text
18. Wolfe ND , Daszak P, Kilpatrick AM, Burke DS. Bushmeat hunting, deforestation, and prediction of zoonotic disease. Emerging Infect Dis 11: 1822-27 (2005) Full text
19. Schwartz IB, Shaw LB, Cummings DAT, Billings L, McCrary M, Burke DS. Chaotic desynchronization of multistrain diseases. Physical Review E 72 (066201): 1- 6 (2005) PMID: 16486034
20. Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithworn S, Burke DS. Evaluation of the likely effectiveness of strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437:209-14 (2005)
21. Cummings DAT, Schwartz IB, Billings L, Shaw LB, Burke DS. Dynamic effects of antibody dependent enhancement on the fitness of viruses. Proc Natl Acad Sci USA 102:15259-64 (2005) Full text
22. Machuca A, Wood O, Lee S, Daniel S, Rios M, Wolfe ND, Carr JK, Eitel MN, Tamoufe U, Torimiro JN, Burke D, Hewlett IK. Seroprevalence of human T cell leukemia virus in HIV antibody-negative populations in rural Cameroon. Clin Infect Dis 40:1673-6 (2005) Full text
23. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A 102: 7994-9 (2005). Full text
24. Gilbert PB, Peterson ML, Follmann D, Francis DP, Gurwith M, Heyward WL, Hudgens MG, Jobes DV, Popovic V, Self SG, Sinangil F, Burke DS, Berman PW. Immunologic responses to rgp120 vaccine correlate with the incidence of HIV-1 infection in a phase 3 preventive HIV-1 vaccine trial. J Infect Dis 191: 666-77 (2005) PMID: 15688279
25. Nguyen JC, Murphy ME, Nutman TB, Neafie RC, Maturo S, Burke DS, Turiansky GW. Tropical Medicine Rounds: Cutaneous onchocerciasis in an American traveler. Intl J Dermatol 44:125-8 (2005)

Back to top